PDRNãšèšãã°ãªãžã¥ã©ã³ãšèšãã»ã©äººæ°ã«ãªãåãã倧人æ°ã®ãªãžã¥ã©ã³ãŽãŒã«ãçŸå®¹æ¶²âšïž ãªãžã¥ã©ã³ã ãã®c-PDRNé åã§è£œè¬äŒç€Ÿãªãã§ã¯ã®ç¬èªæè¡ã§ãèãžã®æµžé*2ãé«ããŠãããŠãæç¶çã«ãèãä¿æ¹¿ããæ¿åçŸå®¹æ¶²ã ããã§ããã ãã£ãã銎æãŸãããšãèããã¡ã£ãšããæããããŠãããªã«ããã«ãã¡ã£ãšãªãã®ïŒïŒãšæãã»ã©äœ¿ãå¿å°ãè¯ãã¢ã³ãã«ðââððž
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬118äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬185äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬16äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬19äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬49äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬78äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬20äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã | |
GUERLAIN ã¢ãã€ãŠ ãã€ã€ã« ãŠã©ãŒã¿ãªãŒ ãªã€ã« ã»ãã | 19,800å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬72äœ | 詳现ãèŠã | ||
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬118äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬135äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
ã¢ãŒã¬ã¹ ããŒã¹ã ãã³ã㌠X | 7,150å(ç·šééšèª¿ã¹/ãªãŒãã³äŸ¡æ Œ) |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬38äœ | ãã¿ãã¿ãã«ããã èãªãã¿ãããã®ã§äœ¿ããããïŒãèã«ãã€ãã§ãã®ãå¬ããð | 詳现ãèŠã | |
ãšãªã¯ã·ãŒã« ãšãªã¯ã·ãŒã«ãã¶ ã»ã©ã aaïŒå»è¬éšå€åïŒ | 8,910å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬106äœ | èåœããã®ããã¯ãªãŒããŒãªãžã§ã«ãããã®è³ªæã§èã«ãããããªããã§ãããŸãã | 詳现ãèŠã |
ðžâ¯ðâ¯ðâ¯ããã®äººæ°ã¯ãã³ã
ãã¯ã¹ãã£ãŒã¯ç²åºŠã¯äœãã§ããªãããäŒžã³ææ©ç³»ã®éŠããããŸãã æŽé¡åŸãŸãã¯åç²§æ°Žã䜿çšããåŸã«é©éãé¡å šäœãŸãã¯éšåçã«è»œãå©ããªããå¡ããŸãã ãã€ã¢ã·ã³ã¢ãããã»ã©ããããã³ãããŒã«ããã¢ã«ãã³é žãªã©é åã®çŸå®¹æ¶²ããã²ãã§ãã¯ããŠã¿ãŠãã ããð«¶ð»
ãã£ãšèŠã67
3
- 2024.07.03
éŠãã¯å ±éããŠTOPæŽæ¢šãMIDDLEããªãŒãžã¢ãBASEã¢ã³ããŒã»ããã§ãªã»ãŠããã®é«çŽæããµããäžåãªéŠãã§ãã æ¿å¯ãªæ³¡ã§å ãŸãããããªæèŠãå³ãããªããæŽããã®ã§å¿å°è¯ãð«§ ããªãŒãã¡ã³ãã§ããã«ãŸãšãŸãããããã€ãæãã髪ãžè²ãŠãŠãããæããè¯ãã£ãã§ãâš
ãã£ãšèŠã66
1
- 2ã¶æå
SPF50+/PA++++ ç¡éŠæ çŸå®¹æ¶²ãåãããäžå°ãç®èã³ã³ãããŒã«ãUVã«ããããã¡ã³ããããããã®7åœ¹ãæ ã£ãŠãããã®ã§ãã¹ãã³ã±ã¢ã®åŸã«ã³ã¬1æ¬ã§ä»äžããããŸãã ã«ã©ãŒå±éã¯00.01.02ã®3è²ã
ãã£ãšèŠã63
3
- 2024.05.18
åŒç· ãã»ä¿æ¹¿ã»é也ãã¢ããã°ã¬ãŒãâ€Žïž é·æéããŒãã§èªç¶ãªãµãããé·æã¡ é也æ§ãªã®ã§ä¹Ÿãåã«ãŸã¶ãã«ä»ããŠãã¬ã€ã«çä»ãã§ããªãããšãªãã«ããã®ã䜿ãåæè¯ãæããŸããðð»
ãã£ãšèŠã62
2
- 3ã¶æå
ç¬èªç¹èš±æåã®ãããã€ãªããŒã â¢ïžãšããå³éžãããåªç§ãªèæ ªãšãå€çš®ã®ããããã³ã³ãã¬ãã¯ã¹ãé åãããŠãããšãããšãåªããéŠããšããã§ãã ãã¡ãã¯ã³ã©ãŒã²ã³ã©ã€ã³ããåºãŠããã»ã©ã ã§ãã³ã©ãŒã²ã³ãšæ¯ç©ŽãããŒã¯ãŒãã«ãªã£ãŠããŠãæåŸ æã®æãŠãå 容ã«ãªã£ãŠããŸãã åã¿ãšã³ã¯ããã£ããããŠããã®ã§åºæã ãã§ãããªãæãããããããªãã¯ã¹ãã£ãŒã«ãªã£ãŠããŸããããã¿ã€ããæããããšãªãå€ã§ã䜿ãå¿å°ãè¯ãã£ãã§ãã
ãã£ãšèŠã62
5
- 2024.08.29
ã話é¡ã®PDRNâ»é åçŸå®¹æ¶²ãâ»å æ°Žåè§£DNAé åç®çïŒä¿æ¹¿æåâãããªæ¹ã«ãªã¹ã¹ã¡ã»ãšã€ãžã³ã°ã±ã¢â»1ããããã»é«ä¿æ¹¿â»2çŸå®¹æ¶²ã䜿ãããã»ãã€èãçŸèã«ä»äžãããã»èèããäºé²ãããâ»1幎霢ã«å¿ãããæå ¥ãâ»2åœç€Ÿæ¯ä»¥äžã¬ãã¥ãŒâð»èŠãç®...
ãã£ãšèŠã61
0
- 3æ¥å
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
åèã«ãªããŸãð¥°